- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02854969
Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
July 25, 2017 updated by: Adan Medical Innovation, SL
Randomized, Cross-over, Open, Unicentric Trial Evaluating Satisfaction With the Use of a Medical Device for the Epinephrine Auto-injector in Patients With Anaphylaxis
Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.
Study Overview
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08035
- Hospital Vall d'Hebron
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 18 years old or above
- Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed
- Patients with a smartphone
- Patients who signed the informed consent
Exclusion Criteria:
- Patients who have not signed the informed consent
- Patients with some limitations for understanding or following correctly the trial procedures
- Pregnant or nursing women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: epinephrine auto-injector
3 months using the epinephrine auto-injector alone, and after that 3 more months using the epinephrine auto-injector + medical device
|
|
Experimental: epinephrine auto-injector + medical device
Device: Anapphylaxis is a medical device with a case for an epinephrine autoinjector that connects via Bluetooth to a mobile application 3 months using the epinephrine auto-injector + medical device , and after that 3 more months using the epinephrine auto-injector alone |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient satisfaction through a questionnaire in the use of the medical device
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical device safety
Time Frame: 3 months
|
Adverse events related to the medical device
|
3 months
|
Patient Adherence to the medical device through a questionnaire
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Actual)
July 18, 2017
Study Completion (Actual)
July 18, 2017
Study Registration Dates
First Submitted
July 22, 2016
First Submitted That Met QC Criteria
August 3, 2016
First Posted (Estimate)
August 4, 2016
Study Record Updates
Last Update Posted (Actual)
July 26, 2017
Last Update Submitted That Met QC Criteria
July 25, 2017
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AnapphylaxisQoL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anaphylaxis
-
University of MichiganThe Gerber FoundationRecruiting
-
National Institute of Allergy and Infectious Diseases...RecruitingIdiopathic Anaphylaxis | Drug Anaphylaxis | Venom Anaphylaxis | Food AnaphylaxisUnited States
-
Central Hospital, Nancy, FranceSanofi; GlaxoSmithKline; Zambon SpA; Laboratoires URGO; Pierre Fabre Medicament; Bi... and other collaboratorsUnknownNeuromuscular Blocking Agents AnaphylaxisFrance
-
University of LeedsUnknownExercise AnaphylaxisUnited Kingdom
-
University Hospital, AngersRecruitingAnaphylaxis Caused by Hymenoptera Venom (Disorder)France
-
Mahidol UniversityCompletedWheat Allergy | Anaphylaxis Food | Anaphylaxis ExerciseThailand
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of MedicineCompleted
-
Massachusetts General HospitalWithdrawnAnaphylaxis as a Result of Allergen or Venom ImmunotherapyUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Siriraj HospitalMahidol UniversityCompleted
Clinical Trials on Device: Anapphylaxis
-
Facet TechnologiesLifeScanCompletedDiabetesUnited States
-
Karolinska InstitutetUnknownDegenerative Disc Disease | Discogenic Low Back PainSweden
-
AOTI Ltd.UnknownDiabetic Foot UlcerUnited Kingdom, United States, Germany, France, Luxembourg
-
International Agency for Research on CancerUniversity of North Carolina Global Project Zambia; Liger Medical LlcCompleted
-
Cala Health, Inc.Not yet recruiting
-
Universitair Ziekenhuis BrusselTerminated
-
University of BernDCB Research AG; Insel Gruppe AG, University Hospital BernActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus | Endocrine System Diseases | Metabolic DiseaseSwitzerland
-
Kasey PhiferThe National Centre for ElectroMagnetic Therapies CICCompletedUnspecified Trauma- and Stressor-Related DisorderUnited Kingdom
-
Neurolief Ltd.Completed
-
Icahn School of Medicine at Mount SinaiTivic Health SystemsRecruiting